{"organizations": [], "uuid": "a4d829dbe563f1e38e566e4f88a3e3279ddca32d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180307.html", "section_title": "Archive News &amp; Video for Wednesday, 07 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zhenxing-biopharmaceutical-chemica/brief-zhenxing-biopharmaceutical-chemical-receives-administrative-order-idUSL4N1QP2HR", "country": "US", "domain_rank": 408, "title": "BRIEF-Zhenxing Biopharmaceutical & Chemical receives administrative order", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.146, "site_type": "news", "published": "2018-03-07T13:56:00.000+02:00", "replies_count": 0, "uuid": "a4d829dbe563f1e38e566e4f88a3e3279ddca32d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zhenxing-biopharmaceutical-chemica/brief-zhenxing-biopharmaceutical-chemical-receives-administrative-order-idUSL4N1QP2HR", "ord_in_thread": 0, "title": "BRIEF-Zhenxing Biopharmaceutical & Chemical receives administrative order", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-zhenxing biopharmaceutical & chemical", "sentiment": "negative"}, {"name": "zhenxing biopharmaceutical & chemical co ltd", "sentiment": "negative"}, {"name": "shanxi regulatory bureau of china securities regulatory commission", "sentiment": "none"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 7(Reuters) - Zhenxing Biopharmaceutical & Chemical Co Ltd\n* Says it received administrative order from Shanxi Regulatory Bureau of China Securities Regulatory Commission on March 5, regarding related transaction, financial report disclosure and internal control issues\nSource text in Chinese: goo.gl/bzx5aK\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/bzx5aK"], "published": "2018-03-07T13:56:00.000+02:00", "crawled": "2018-03-08T17:18:36.002+02:00", "highlightTitle": ""}